Related Experiment Videos
T and Tk transformation in hemolytic uremic syndromes
R Lynen1, H Neumeyer, B Schulte
1Klinikum der Universität Göttingen.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy
|January 1, 1990
Summary
Lectin red cell agglutination tests helped identify bacterial causes in hemolytic uremic syndrome (HUS). Anti-T and anti-Tk antibodies may play a role, while fresh plasma transfusions were safe. Disseminated intravascular coagulation (DIC) led to a fatal outcome in one case.
Area of Science:
- Microbiology
- Immunology
- Hematology
Background:
- Hemolytic uremic syndrome (HUS) is a serious condition often linked to bacterial infections.
- Understanding the specific bacterial pathogenesis is crucial for effective treatment and management.
Purpose of the Study:
- To elucidate the bacterial pathogenesis in two cases of hemolytic uremic syndrome (HUS).
- To investigate the potential role of anti-T and anti-Tk antibodies in HUS.
- To evaluate the safety and efficacy of fresh plasma transfusions in HUS patients.
Main Methods:
- Lectin red cell agglutination tests were employed to identify bacterial agents.
- Clinical data and patient outcomes were analyzed.
Main Results:
- Bacterial pathogenesis was successfully elucidated in both HUS cases using lectin red cell agglutination tests.
- The study discusses the potential involvement of anti-T and anti-Tk antibodies.
- Transfusions of fresh plasma were administered without adverse effects.
- Disseminated intravascular coagulation (DIC) was identified as the cause of death in one patient.
Conclusions:
- Lectin red cell agglutination tests are valuable tools for determining bacterial pathogenesis in HUS.
- Anti-T and anti-Tk antibodies may be implicated in the disease process.
- Fresh plasma transfusions appear to be a safe supportive measure in HUS management.
- DIC remains a significant risk factor for mortality in HUS.